1. Home
  2. SERA

SERA

Sera Prognostics Inc.

Logo Sera Prognostics Inc.

Health Care

Precision Instruments

Nasdaq

as 04-17-2024 11:46am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.

Founded: 2008 Country:
United States
United States
Employees: N/A City: SALT LAKE CITY
Market Cap: 364.8M IPO Year: 2021
Target Price: $2.75 AVG Volume (30 days): 237.1K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.16 EPS Growth: N/A
52 Week Low/High: $1.52 - $11.32 Next Earning Date: 05-08-2024
Revenue: $306,000 Revenue Growth: 14.18%
Revenue Growth (this year): 50% Revenue Growth (next year): 1955.56%

Share on Social Networks: